Canagliflozin pretreatment attenuates myocardial dysfunction and improves postcardiac arrest outcomes after cardiac arrest and cardiopulmonary resuscitation in mice

HIGHLIGHTS

  • who: Feng Ju et al. from the Laboratory of Anesthesia and Critical Care Medicine, of Anesthesiology, China Hospital, Sichuan University have published the paper: Canagliflozin Pretreatment Attenuates Myocardial Dysfunction and Improves Postcardiac Arrest Outcomes After Cardiac Arrest and Cardiopulmonary Resuscitation in Mice, in the Journal: (JOURNAL)
  • what: The aim of this study was to examine the protective effect of pretreatment on postresuscitation-induced cardiac dysfunction in vivo. The authors investigated the hypothesis that canagliflozin may attenuate myocardial injury after resuscitation using a non-diabetic mouse model of sudden cardiac arrest. To further understand the protective . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?